Related Articles
Self‑renewal signaling pathways and differentiation therapies of glioblastoma stem cells (Review)
Identification of prognostic biomarkers for glioblastomas using protein expression profiling
Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges (Review)
Mutation of the TERT promoter leads to poor prognosis of patients with non‑small cell lung cancer
Oncogenic miR‑132 sustains proliferation and self‑renewal potential by inhibition of polypyrimidine tract‑binding protein 2 in glioblastoma cells